William Keller

William Keller

Fortune : 93 157 $ au 31/05/2026

77 ans
Health Technology
Process Industries
Finance

Profil

William Robert Keller was the founder of Keller Pharma Consultancy (Shanghai) Co. Ltd., founded in 2003, where the title held was General Manager from 2012 to 2014.
Current jobs include Chairman at Coland Holdings Ltd. since 2010; Director at Shanghai Guo Chuang Pharmaceutical Co., Ltd. since 2020; Director at Cathay Biotech, Inc. since 2019; Independent Non-Executive Director at WuXi Biologics (Cayman), Inc. since 2017; Independent Non-Executive Director at Hua Medicine Ltd. since 2018; Independent Director at Gland Pharma Ltd. starting 2026; President at Pharmaceutical Association of Shijiazhuang City; and Vice President at Roche Diagnóstica Brasil Ltda.
Former jobs include Chairman at HBM BioMed China Partners Ltd from 2009 to 2010; Chairman at Coland Pharmaceutical Co., Ltd. from 2010 to 2020; Vice Chairman at Shanghai Association of Enterprises With Foreign Investment from 1997 to 2013; Independent Director at Alexion Pharmaceuticals, Inc. from 2009 to 2015; Independent Director at Wuxi PharmaTech (Cayman), Inc. from 2014 to 2015; Independent Director at China Nuokang Bio-Pharmaceutical, Inc. from 2010 to 2011; Director at Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; Director at Cathay Industrial Biotech Ltd. from 2008 to 2011; Independent Director at Fosun Pharma Group Co. Ltd.; Independent Director at Artisan Acquisition Corp.; General Manager at Hoffmann-La Roche, Inc. from 1972 to 2003; General Manager at Productos Roche SA; Member-Supervisory Board at TaiGen Biopharmaceuticals Holdings Ltd. from 2011 to 2014; General Manager at Shanghai Roche Pharmaceutical Co., Ltd. from 1994 to 2003; General Manager at Roche (China) Investment Co., Ltd. from 1994 to 2003; Deputy General Manager at Produtos Roche Químicos e Farmacêuticos SA; Deputy General Manager at Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd from 2003 to 2014.
Education includes an undergraduate degree from the School of Economics & Business Administration, conferred in 1972.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2025 21 899 ( 0 % ) 93 157 $ 31/05/2026

Postes actifs de William Keller

SociétésPosteDébut
COLAND HOLDINGS LIMITED Président 05/12/2010
WUXI BIOLOGICS (CAYMAN) INC. Directeur/Membre du Conseil 17/05/2017
HUA MEDICINE (SHANGHAI) LTD. Directeur/Membre du Conseil 26/08/2018
CATHAY BIOTECH INC. Directeur/Membre du Conseil 18/08/2019
GLAND PHARMA LIMITED Directeur/Membre du Conseil 15/06/2026
Directeur/Membre du Conseil 01/12/2020
Corporate Officer/Principal -
Pharmaceutical Association of Shijiazhuang City
President -

Anciens postes connus de William Keller

SociétésPosteFin
Président 01/12/2020
░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de William Keller

Formation de William Keller

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

75

Relations au 1er degré

27

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées27

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Health Technology

Finance

Pharmaceutical Association of Shijiazhuang City

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Consumer Services

Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd

Keller Pharma Consultancy (Shanghai) Co. Ltd.

Health Technology

Health Technology

Health Technology

Shanghai Association of Enterprises With Foreign Investment

Health Technology

Health Technology

Process Industries

Fosun Pharma Group Co. Ltd.

Finance

  1. Bourse
  2. Insiders
  3. William Keller
🔇